Pathogen Readiness News Today

The World Health Organizations governing body is scheduled to meet on May 27 to discuss a critically needed plan for global pandemic preparedness.

Concurrent administration of the bivalent COVID-19 booster and influenza vaccines may yield stronger and longer-lasting SARS-CoV-2 nAb responses.

The concentration of COVID-19 in Greater Boston's wastewater is at its second-highest level since the start of the pandemic.

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

• Stapled lipopeptides successfully deter infection by the SARS-CoV-2 virus and reduce the severity of COVID-19 in tests with hamsters

Novel insights from the pandemic may be propelling the field of immunology into a new golden age.

Novel insights from the pandemic may be propelling the field of immunology into a new golden age.

The global COVID-19 vaccination campaign saved an estimated 20 million lives. However, while current COVID-19 vaccines provide protection against developing severe disease, they do little to prevent infection and transmission.

<p>Findings published in the journal <em><a href="https://www.nature.com/articles/s41586-023-06951-3">Nature</a> </em>by physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) and colleagues suggest that it may be possible to improve protection against COVID-19 by delivering the vaccine directly to the respiratory tract— the primary site of entry in SARS-CoV-2 infection.</p>

<p>A new study by investigators from <a href="https://www.massgeneralbrigham.org/">Mass General Brigham</a> found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test—a phenomenon known as virologic rebound. By contrast, people not taking Paxlo...